ARTICLE | Politics, Policy & Law
Trade deal elicits Chinese promises to align pharma IP with U.S. Hatch-Waxman paradigm
In win for innovators on both sides of the Pacific, U.S.-China trade deal commits China to patent linkage
January 18, 2020 3:56 AM UTC
Updated on Jan 18, 2020 at 5:54 AM UTC
A combination of pressure from the U.S. government and admonitions from domestic and multinational innovative drug manufacturers have led the Chinese government to agree to align its pharmaceutical patent laws with those of developed countries.
The commitments are consistent with promises the Chinese Communist Party and the Chinese government made in October 2017 (see “Time to Fulfill China’s Promise of IP Reform”). ...